| Title | Author(s) | Year | View Count |
 | Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b | Fan, NY; Tsang, FH; Tam, HKA; Au, LKS; Wong, CCL; Wei, L; Lee, MF; He, XH; Ng, IOL; Wong, CM | 2013 | 9 |
 | Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis | Au, LKS; Wong, CCL; Lee, MF; Fan, NY; Tsang, FH; Ng, IOL; Wong, CM | 2012 | 62 |
 | C-terminal truncated HBx is associated with metastasis and enhances invasiveness via C-Jun / MMP10 activation in hepatocellular carcinoma | Sze, MF; Chu, KY; Lee, MF; Ng, IOL | 2012 | 52 |
 | The centrosomal protein Tax1 binding protein 2 is a novel tumour suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2 | Lai, WL; Hung, WY; Wong, LLY; Zhou, Y; Leong, VYL; Lee, MF; Ng, IOL; Jin, D; Ching, YP | 2012 | 112 |
 | Up-regulation of histone methyltransferase SUV39H1 promotes liver cancer growth and metastasis | Fan, NY; Tsang, FH; Au, LKS; Tam, HKA; Wong, CCL; Wei, L; Lee, MF; Ng, IOL; Wong, CM | 2012 | 73 |
 | Overexpression of Enhancer of Zeste homolog 2 (EZH2) promotes HCC metastasis via epigenetic silencing of multiple anti-metastatic microRNAs | Au, LKS; Wong, CCL; Lee, MF; Fan, NY; Ng, IOL; Wong, CM | 2012 | 53 |
 | Overexpression of Enhancer of Zeste homolog 2 (EZH2) promotes HCC metastasis via epigenetic silencing of multiple anti-metastatic microRNAs | Au, LKS; Wong, CCL; Lee, MF; Fan, NY; Ng, IOL; Wong, CM | 2011 | 39 |
 | Frequent upregulation of enhancer of zeste homolog 2 was implicated in deleted in liver cancer 1 gene silencing and HCC progression | Au, LK; Wong, CCL; Lee, MF; Wong, CM; Ng, IOL | 2010 | 682 |
 | Overexpression of enhancer of zeste homolog 2 was implicated in hepatocellular carcinoma metastasis via epigenetic silencing of deleted in liver cancer 1 | Au, LK; Wong, CCL; Lee, MF; Wong, CM; Ng, IOL | 2010 | 52 |
 | Rho-kinase 2 (ROCK2) is involved in hepatocellular carcinoma progression, metastasis and invasion | Wong, CL; Wong, CM; Tung, EK; Lee, MF; Man, K; Ng, IOL | 2008 | 119 |
 | P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation | Ching, YP; Leong, VYL; Lee, MF; Xu, HT; Jin, DY; Ng, IOL | 2007 | 199 |
 | Pak1 overexpression is important in the metastasis of hepatocellular carcinoma | Ching, YP; Leong, VYL; Lee, MF; Ng, IOL | 2006 | 76 |
 | HDPR1, a novel inhibitor of the WNT/β-catenin signaling, is frequently downregulated in hepatocellular carcinoma: Involvement of methylation-mediated gene silencing | Yau, TO; Chan, CY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2005 | 64 |
 | Under-expression of HDPR1, a novel inhibitor of WNT/b-catenin signaling pathway, in hepatocellular carcinoma (Abstract) | Yau, TO; Chan, CY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2005 | 76 |
 | Frequent down-regulation of HDPR1, a novel inhibitor of WNT/beta-catenin signaling, in hepatocellular carcinoma (Abstract) | Yau, TO; Chan, PCY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2005 | 82 |
 | Under-expression of HDPR1, a novel inhibitor of WNT/b-catenin signaling pathway, in hepatocellular carcinoma (Abstract) | Yau, TO; Chan, PCY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2004 | 91 |
 | HDPR1, a novel inhibitor of WNT/b-catenin signaling, is down-regulated in hepatocellular carcinoma: involvement of promoter hypermethylation | Yau, TO; Chan, ACY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2004 | 81 |
 | High frequency of chimerism in transplanted livers (Abstract) | Ng, IOL; Chan, KL; Shek, TWH; Lee, MF; Fong, DYT; Lo, CM; Fan, ST | 2004 | 55 |
 | Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IOL | Yau, TO; Chan, PCY; Chan, KL; Lee, MF; Wong, CM; Fan, ST; Ng, IOL | 2004 | 125 |
 | Characterization of H-cadherin expression in human hepatocellular carcinoma | Chan, DW; Lee, MF; Ng, IOL | 2004 | 66 |
|